London newspaper reveals ‘shocking evidence’ about transgender treatments

BioEdge

Michael Cook*

After a legal battle The Mail on Sunday has published what it called “shocking evidence” about transgender medicine which led a High Court judge to ban a government gender clinic from prescribing puberty-blockers.

The Gender Identity Development Service (GIDS) clinic in London, also known as the Tavistock Centre, began prescribing these for children under 16 in 2011. In December the clinic was forced to stop after the Court ruled that it was “very doubtful” that youngsters could give informed consent of puberty blockers is basically “a live experiment” on vulnerable children.

Swedish psychiatrist Christopher Gillberg testified that the use of puberty blockers is basically “a live experiment” on vulnerable children.”In my years as a physician,” he wrote, “I cannot remember an issue of greater significance for the practice of medicine. We have left established evidence-based clinical practice and are using powerful life-altering medication for a vulnerable group of adolescents and children based upon a belief.” . . . [Full text]

‘A live experiment on children’

Testimony that led a High Court judge to ban NHS’s Tavistock clinic from giving puberty blocking drugs to youngsters as young as 10 who want to change sex

Daily Mail

Sanchez Manning

The shocking evidence that convinced a High Court judge to effectively ban an NHS gender clinic from giving puberty-blocking drugs to children can be revealed for the first time today.

Until now a court order has prevented the testimony of eminent physicians being made public. But lawyers for The Mail on Sunday successfully argued there was a significant public interest in disclosing the material.

Among the devastating statements that can now be divulged is one from Professor Christopher Gillberg, an expert in child and adolescent psychiatry, who believes prescribing drugs to delay puberty – a first step in gender treatment – is a scandal and tantamount to conducting ‘a live experiment’ on vulnerable children.

‘In my years as a physician, I cannot remember an issue of greater significance for the practice of medicine,’ he said. 

‘We have left established evidence-based clinical practice and are using powerful life-altering medication for a vulnerable group of adolescents and children based upon a belief.’ . . . continue reading

Could the threat of lawsuits rein in gender dysphoria doctors?

BioEdge

Michael Cook

Critics of transgender treatment for children have been making heavy weather of persuading people that it could be medically dangerous. However, a well-documented feature in The Australian warns that transgender doctors could face class action suits if they continue to ignore research which claims that children are being harmed. . . [Full text]

‘Reluctant to prescribe’: Local clinic says women wait weeks to access abortion pill

The executive director of the SHORE Centres says many family doctors are still not prescribing the pill

CBC News

Paula Duhatschek

A local sexual health resource centre says it’s experiencing so much demand for the abortion pill, Mifegymiso, that patients often must wait two to three weeks to get it. 

Mifegymiso is the brand name for the combination of two pills that is used to terminate pregnancies—but only up to nine weeks along. . .[Full text]